Regulatory & Standards Task Force



The mission of the Digital Pathology Association Regulatory and Standards Task Force is to advance digital pathology by bringing clarity to the regulatory pathway for digital pathology including its evolution and creating awareness thereof, and working towards the development and adoption of standards as well as promoting interoperability in digital pathology for clinical use.


Participation in this Task Force is open to Benefactor member representatives only.

DPA’s comments on Federal RN for having certain medical devices exempt (click to read the full comment letter)


Making Permanent Regulatory Flexibilities Provided During the COVID–19 Public Health Emergency by Exempting Certain Medical Devices From Premarket Notification Requirements | Click HERE to access the federal register 

Task Force Members


Co-Chairs: John Groth + Heather Jalisi


  • Esther Abels, MSc, SolarisRTC LLC
  • Pinky Bautista, Bristol-Myers Squibb
  • Scott Blakely, Hamamatsu Corporation
  • Nathan Buchbinder, Proscia Inc.
  • Laura Chang, PhD, Artera
  • Chhavi Chauhan, MS, PhD, ELS, American Society for Investigative Pathology
  • Stephanie Cheng, PathAI
  • Cheng Cui, AstraZeneca
  • Bryce Dzialo, Hologic, Inc.
  • Eric Glassy, MD, Affiliated Pathologists Medical Group, Inc.
  • John Groth, MD, Endeavor Health
  • Markus Herrmann, MD, PhD, Roche
  • Mufaddal Jafferji, Paige
  • Heather Jalisi, Leica Biosystems
  • Liselotte Kornmann, PhD, Philips
  • Yael Liebes Peer, Ibex Medical Analytics
  • Handy Oen, MBA, CT, MB (ASCP), Memorial Sloan Kettering Cancer Center
  • Michael Quick, CT(ASCP), Hologic, Inc.
  • Kim Rendon, Proscia Inc.
  • Jennifer Samboy, MHA, Philips
  • Patricia van Doornmalen, Philips
  • Thomas Westerling-Bui, PhD, Aiforia
  • Zachary Wilczynski, Artera
  • David Witt, Bristol-Myers Squibb